Preventing Nonmicrobiologic Airborne Contamination in the Compounding Pharmacy: Ensuring a Safe Environment for Compounders, Staff, and Clients
Download in electronic PDF format for $75
Abstract: Preventing and minimizing exposure to nonmicrobiologic airborne contaminants in a compounding pharmacy protects the health of pharmacy staff and clients. The inhalation of hazardous substances has been linked to development of diseases and disorders that range from cancer to infertility. Although a workplace environmental exposure level has been established for some antibiotics, at the time of this writing there were no exposure limits recommended by the National Institute for Occupational Safety and Health or permitted by the Occupational Safety and Health Administration for hazardous drugs or pharmaceutical compounds, nor were threshold limit values for those substances specified by the American Conference of Governmental Industrial Hygienists. For that reason, an evaluation of environmental air quality performed by an industial hygienist can yield valuable information that will reassure staff or provide the basis for remedial action. This report describes the assessment by an industrial hygienist of airbor
Related Keywords:
airborne contaminants, workplace safety, worker health, occupational exposure, standards, industrial hygiene, hormones, sex steroids, air quality monitoring, pharmacy staff, employees
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Preventing Nonmicrobiologic Airborne Contamination in the Compounding Pharmacy: Ensuring a Safe Environment for Compounders, Staff, and Clients
Mixon Bill, Ille Gary
|
Jul/Aug 2009
Pg. 290-294
|
Safety Standards in Pharmaceutical Compounding, Part 1: The Occupational Safety and Health Administration
Greeson Nicole MH, Mixon William, Allan W Chris
|
Jul/Aug 2020
Pg. 270-276
|
Safety Standards in Pharmaceutical Compounding, Part 3: Fire Safety
Allen W Chris, Greeson Nicole MH, Mixon William
|
Nov/Dec 2020
Pg. 451-458
|
Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists
Mixon Bill, Nain John
|
May/Jun 2013
Pg. 182-190
|
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations
Ashe Krystina, Baskett Dustin
|
Sep/Oct 2018
Pg. 387-398
|
Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 446-448
|
Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance
Greeson Nicole MH, Mixon William, Allan W Chris
|
Sep/Oct 2020
Pg. 371-379
|
Quality Control Analytical Methods: A Growing Codependency: Compounding Pharmacy and Safety
Prince Bryan, Lundeval Jeremy
|
Nov/Dec 2013
Pg. 485-489
|
PreScription: Permissible Exposure Limits and United States Pharmacopeia Chapter <800>
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 356
|
Trace Level Analysis of Airborne Hormone Particulates
Trimble John O, Hampton Shanna
|
May/Jun 2018
Pg. 257-263
|
Development of Stable and Simple Finasteride 333-μg/mL Suspensions that Minimize Occupational Exposure
Ma Nathan, Perks William, Law Shirley, Iazzetta John, Walker Scott
|
Nov/Dec 2020
Pg. 519-527
|
Pharmacies on the Frontline: Responding to the COVID-19 Pandemic
McElhiney Linda F
|
Jul/Aug 2020
Pg. 287-295
|
How to Develop and Maintain a Hazardous Drug List
Dillon L Rad
|
May/Jun 2019
Pg. 182-186
|
Contamination Control in Compounding Areas
Mulder Kyle, Gonzales Ben A
|
Jul/Aug 2019
Pg. 271-278
|
Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies
Pritchett Jon, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 7-16
|
Vial Washers for the Compounding Pharmacy: Ensuring Preparation Safety
Johnson Kain, Sully Andrew, Anthenat Bruce
|
Jul/Aug 2014
Pg. 270-276
|
Certification of Powder-containment Hoods for Nonsterile Compounding
Mulder Kyle, Dozzi Raphael
|
Sep/Oct 2018
Pg. 369-384
|
Evaluation of Containment Ventilated Enclosure Performance in Absence of Negative Pressure Containment Secondary Engineering Control
Hutson Chad, Day A J
|
Nov/Dec 2019
Pg. 511-518
|
Primary Engineering Controls in Pharmaceutical Compounding, Part 2: Biosafety Cabinets
Mulder Kyle
|
Jan/Feb 2020
Pg. 7-12
|
Quality Control Analytical Methods: Strategies to Ensure a Robust Quality-control Microbiology Program
Griffiths Tricia, Connors Anne
|
Mar/Apr 2013
Pg. 130-134
|
| Return to Top |
